nodes	percent_of_prediction	percent_of_DWPC	metapath
Ziprasidone—DRD4—conduct disorder	0.411	0.485	CbGaD
Ziprasidone—SLC6A4—conduct disorder	0.247	0.291	CbGaD
Ziprasidone—HTR2A—conduct disorder	0.19	0.224	CbGaD
Ziprasidone—HTR7—autonomic nervous system—conduct disorder	0.00362	0.182	CbGeAlD
Ziprasidone—Lurasidone—HTR2A—conduct disorder	0.00231	0.331	CrCbGaD
Ziprasidone—HTR2A—autonomic nervous system—conduct disorder	0.00225	0.113	CbGeAlD
Ziprasidone—Aripiprazole—DRD4—conduct disorder	0.00119	0.171	CrCbGaD
Ziprasidone—DRD4—brain—conduct disorder	0.00111	0.0558	CbGeAlD
Ziprasidone—HTR1E—brain—conduct disorder	0.000959	0.0482	CbGeAlD
Ziprasidone—CHRM4—brain—conduct disorder	0.000841	0.0422	CbGeAlD
Ziprasidone—DRD3—brain—conduct disorder	0.000781	0.0393	CbGeAlD
Ziprasidone—HTR6—brain—conduct disorder	0.000752	0.0378	CbGeAlD
Ziprasidone—DRD5—brain—conduct disorder	0.000732	0.0368	CbGeAlD
Ziprasidone—Aripiprazole—SLC6A4—conduct disorder	0.000716	0.103	CrCbGaD
Ziprasidone—Trazodone—SLC6A4—conduct disorder	0.000713	0.102	CrCbGaD
Ziprasidone—CHRM5—brain—conduct disorder	0.000657	0.033	CbGeAlD
Ziprasidone—Clozapine—DRD4—conduct disorder	0.000641	0.0921	CrCbGaD
Ziprasidone—ADRA1B—brain—conduct disorder	0.0006	0.0302	CbGeAlD
Ziprasidone—H1F0—brain—conduct disorder	0.000567	0.0285	CbGeAlD
Ziprasidone—DRD1—brain—conduct disorder	0.00056	0.0281	CbGeAlD
Ziprasidone—Aripiprazole—HTR2A—conduct disorder	0.00055	0.079	CrCbGaD
Ziprasidone—Trazodone—HTR2A—conduct disorder	0.000548	0.0786	CrCbGaD
Ziprasidone—HTR3A—brain—conduct disorder	0.00054	0.0271	CbGeAlD
Ziprasidone—HTR1B—brain—conduct disorder	0.000453	0.0228	CbGeAlD
Ziprasidone—CHRM2—brain—conduct disorder	0.000451	0.0227	CbGeAlD
Ziprasidone—HTR1D—brain—conduct disorder	0.000439	0.022	CbGeAlD
Ziprasidone—HTR2C—brain—conduct disorder	0.000435	0.0218	CbGeAlD
Ziprasidone—SLC6A4—brain—conduct disorder	0.000412	0.0207	CbGeAlD
Ziprasidone—CHRM1—brain—conduct disorder	0.00041	0.0206	CbGeAlD
Ziprasidone—CHRM3—brain—conduct disorder	0.000367	0.0185	CbGeAlD
Ziprasidone—HTR1A—brain—conduct disorder	0.000366	0.0184	CbGeAlD
Ziprasidone—HTR7—brain—conduct disorder	0.00035	0.0176	CbGeAlD
Ziprasidone—ADRA1A—brain—conduct disorder	0.000337	0.0169	CbGeAlD
Ziprasidone—DRD2—brain—conduct disorder	0.000331	0.0166	CbGeAlD
Ziprasidone—KCNH2—brain—conduct disorder	0.000326	0.0164	CbGeAlD
Ziprasidone—ADRA2C—brain—conduct disorder	0.000321	0.0161	CbGeAlD
Ziprasidone—Clozapine—HTR2A—conduct disorder	0.000296	0.0425	CrCbGaD
Ziprasidone—HRH1—brain—conduct disorder	0.000261	0.0131	CbGeAlD
Ziprasidone—ADRA2A—brain—conduct disorder	0.000256	0.0129	CbGeAlD
Ziprasidone—HTR2A—brain—conduct disorder	0.000218	0.011	CbGeAlD
Ziprasidone—CYP2D6—brain—conduct disorder	0.000199	0.00998	CbGeAlD
Ziprasidone—HTR1B—Signaling Pathways—CGA—conduct disorder	5.23e-05	0.000417	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—CGA—conduct disorder	5.14e-05	0.00041	CbGpPWpGaD
Ziprasidone—HTR6—Signaling by GPCR—DRD4—conduct disorder	5.1e-05	0.000406	CbGpPWpGaD
Ziprasidone—HTR7—Signaling by GPCR—DRD4—conduct disorder	5.09e-05	0.000406	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—CGA—conduct disorder	5.07e-05	0.000404	CbGpPWpGaD
Ziprasidone—CHRM5—GPCR downstream signaling—DRD4—conduct disorder	5.07e-05	0.000404	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling by GPCR—DRD4—conduct disorder	5.06e-05	0.000403	CbGpPWpGaD
Ziprasidone—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	5.03e-05	0.000401	CbGpPWpGaD
Ziprasidone—ADRA2B—GPCR ligand binding—HTR2A—conduct disorder	4.97e-05	0.000396	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling by GPCR—DRD4—conduct disorder	4.95e-05	0.000395	CbGpPWpGaD
Ziprasidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	4.95e-05	0.000395	CbGpPWpGaD
Ziprasidone—CHRM2—SIDS Susceptibility Pathways—EP300—conduct disorder	4.94e-05	0.000394	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling by GPCR—HTR2A—conduct disorder	4.87e-05	0.000388	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—CGA—conduct disorder	4.86e-05	0.000387	CbGpPWpGaD
Ziprasidone—DRD1—GPCR downstream signaling—DRD4—conduct disorder	4.83e-05	0.000385	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling by GPCR—DRD4—conduct disorder	4.81e-05	0.000383	CbGpPWpGaD
Ziprasidone—HTR1A—GPCR ligand binding—HTR2A—conduct disorder	4.8e-05	0.000382	CbGpPWpGaD
Ziprasidone—HTR2C—GPCR ligand binding—HTR2A—conduct disorder	4.77e-05	0.00038	CbGpPWpGaD
Ziprasidone—DRD3—GPCR downstream signaling—DRD4—conduct disorder	4.77e-05	0.00038	CbGpPWpGaD
Ziprasidone—DRD5—GPCR downstream signaling—HTR2A—conduct disorder	4.75e-05	0.000378	CbGpPWpGaD
Ziprasidone—CYP3A7—Metabolism—CGA—conduct disorder	4.74e-05	0.000378	CbGpPWpGaD
Ziprasidone—ADRA2C—GPCR ligand binding—HTR2A—conduct disorder	4.64e-05	0.00037	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	4.64e-05	0.00037	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—CGA—conduct disorder	4.63e-05	0.000369	CbGpPWpGaD
Ziprasidone—ADRA2C—Metabolism—CGA—conduct disorder	4.61e-05	0.000367	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling by GPCR—DRD4—conduct disorder	4.61e-05	0.000367	CbGpPWpGaD
Ziprasidone—ADRA1B—GPCR ligand binding—HTR2A—conduct disorder	4.57e-05	0.000364	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—CGA—conduct disorder	4.57e-05	0.000364	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—DRD4—conduct disorder	4.41e-05	0.000351	CbGpPWpGaD
Ziprasidone—DRD1—Signaling by GPCR—DRD4—conduct disorder	4.39e-05	0.00035	CbGpPWpGaD
Ziprasidone—DRD3—Signaling by GPCR—DRD4—conduct disorder	4.33e-05	0.000345	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—WASF1—conduct disorder	4.31e-05	0.000344	CbGpPWpGaD
Ziprasidone—DRD5—Signaling by GPCR—HTR2A—conduct disorder	4.31e-05	0.000343	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—WASF1—conduct disorder	4.3e-05	0.000343	CbGpPWpGaD
Ziprasidone—ADRA2B—GPCR downstream signaling—DRD4—conduct disorder	4.3e-05	0.000343	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—WASF1—conduct disorder	4.28e-05	0.000341	CbGpPWpGaD
Ziprasidone—DRD2—GPCR ligand binding—HTR2A—conduct disorder	4.21e-05	0.000336	CbGpPWpGaD
Ziprasidone—CYP3A4—Biological oxidations—COMT—conduct disorder	4.21e-05	0.000335	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—WASF1—conduct disorder	4.19e-05	0.000334	CbGpPWpGaD
Ziprasidone—CYP3A4—Biological oxidations—MAOA—conduct disorder	4.18e-05	0.000333	CbGpPWpGaD
Ziprasidone—DRD2—Circadian rythm related genes—EP300—conduct disorder	4.18e-05	0.000333	CbGpPWpGaD
Ziprasidone—HTR1A—GPCR downstream signaling—DRD4—conduct disorder	4.16e-05	0.000331	CbGpPWpGaD
Ziprasidone—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	4.15e-05	0.000331	CbGpPWpGaD
Ziprasidone—HRH1—GPCR ligand binding—HTR2A—conduct disorder	4.14e-05	0.00033	CbGpPWpGaD
Ziprasidone—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	4.13e-05	0.00033	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—CGA—conduct disorder	4.12e-05	0.000329	CbGpPWpGaD
Ziprasidone—CHRM1—GPCR ligand binding—HTR2A—conduct disorder	4.12e-05	0.000329	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—WASF1—conduct disorder	4.12e-05	0.000328	CbGpPWpGaD
Ziprasidone—CHRM3—GPCR ligand binding—HTR2A—conduct disorder	4.11e-05	0.000328	CbGpPWpGaD
Ziprasidone—CHRM1—Circadian rythm related genes—EP300—conduct disorder	4.09e-05	0.000326	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—CGA—conduct disorder	4.08e-05	0.000325	CbGpPWpGaD
Ziprasidone—CHRM2—GPCR ligand binding—HTR2A—conduct disorder	4.07e-05	0.000324	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—WASF1—conduct disorder	4.07e-05	0.000324	CbGpPWpGaD
Ziprasidone—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	4.06e-05	0.000323	CbGpPWpGaD
Ziprasidone—ADRA2C—GPCR downstream signaling—DRD4—conduct disorder	4.02e-05	0.000321	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—CGA—conduct disorder	3.98e-05	0.000317	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—CGA—conduct disorder	3.96e-05	0.000316	CbGpPWpGaD
Ziprasidone—ADRA1B—GPCR downstream signaling—DRD4—conduct disorder	3.96e-05	0.000315	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling by GPCR—DRD4—conduct disorder	3.91e-05	0.000312	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—DRD4—conduct disorder	3.9e-05	0.000311	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—WASF1—conduct disorder	3.89e-05	0.00031	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—CGA—conduct disorder	3.85e-05	0.000307	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—CGA—conduct disorder	3.79e-05	0.000302	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling by GPCR—DRD4—conduct disorder	3.77e-05	0.000301	CbGpPWpGaD
Ziprasidone—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	3.77e-05	0.000301	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling by GPCR—DRD4—conduct disorder	3.75e-05	0.000299	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—CGA—conduct disorder	3.74e-05	0.000298	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—WASF1—conduct disorder	3.71e-05	0.000296	CbGpPWpGaD
Ziprasidone—HTR6—GPCR downstream signaling—HTR2A—conduct disorder	3.66e-05	0.000292	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—WASF1—conduct disorder	3.66e-05	0.000292	CbGpPWpGaD
Ziprasidone—HTR7—GPCR downstream signaling—HTR2A—conduct disorder	3.66e-05	0.000292	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling by GPCR—DRD4—conduct disorder	3.65e-05	0.000291	CbGpPWpGaD
Ziprasidone—DRD2—GPCR downstream signaling—DRD4—conduct disorder	3.65e-05	0.000291	CbGpPWpGaD
Ziprasidone—HTR1D—GPCR downstream signaling—HTR2A—conduct disorder	3.63e-05	0.00029	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling by GPCR—DRD4—conduct disorder	3.59e-05	0.000286	CbGpPWpGaD
Ziprasidone—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	3.59e-05	0.000286	CbGpPWpGaD
Ziprasidone—HRH1—GPCR downstream signaling—DRD4—conduct disorder	3.58e-05	0.000286	CbGpPWpGaD
Ziprasidone—CHRM1—GPCR downstream signaling—DRD4—conduct disorder	3.57e-05	0.000285	CbGpPWpGaD
Ziprasidone—CHRM3—GPCR downstream signaling—DRD4—conduct disorder	3.56e-05	0.000284	CbGpPWpGaD
Ziprasidone—HTR1B—GPCR downstream signaling—HTR2A—conduct disorder	3.56e-05	0.000284	CbGpPWpGaD
Ziprasidone—CHRM2—GPCR downstream signaling—DRD4—conduct disorder	3.52e-05	0.000281	CbGpPWpGaD
Ziprasidone—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	3.52e-05	0.00028	CbGpPWpGaD
Ziprasidone—DRD4—GPCR downstream signaling—HTR2A—conduct disorder	3.5e-05	0.000279	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CGA—conduct disorder	3.49e-05	0.000279	CbGpPWpGaD
Ziprasidone—CHRM4—GPCR downstream signaling—HTR2A—conduct disorder	3.46e-05	0.000275	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CGA—conduct disorder	3.44e-05	0.000274	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CGA—conduct disorder	3.43e-05	0.000274	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—CGA—conduct disorder	3.43e-05	0.000273	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CGA—conduct disorder	3.42e-05	0.000273	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CGA—conduct disorder	3.41e-05	0.000272	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CGA—conduct disorder	3.38e-05	0.000269	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CGA—conduct disorder	3.37e-05	0.000268	CbGpPWpGaD
Ziprasidone—HTR6—Signaling by GPCR—HTR2A—conduct disorder	3.33e-05	0.000265	CbGpPWpGaD
Ziprasidone—HTR7—Signaling by GPCR—HTR2A—conduct disorder	3.32e-05	0.000265	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—DRD4—conduct disorder	3.31e-05	0.000264	CbGpPWpGaD
Ziprasidone—CHRM5—GPCR downstream signaling—HTR2A—conduct disorder	3.31e-05	0.000264	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—WASF1—conduct disorder	3.3e-05	0.000263	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling by GPCR—HTR2A—conduct disorder	3.3e-05	0.000263	CbGpPWpGaD
Ziprasidone—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	3.27e-05	0.00026	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—DRD4—conduct disorder	3.26e-05	0.00026	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—DRD4—conduct disorder	3.25e-05	0.000259	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—DRD4—conduct disorder	3.24e-05	0.000258	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—DRD4—conduct disorder	3.23e-05	0.000258	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling by GPCR—HTR2A—conduct disorder	3.23e-05	0.000258	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—DRD4—conduct disorder	3.2e-05	0.000255	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	3.19e-05	0.000254	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—WASF1—conduct disorder	3.19e-05	0.000254	CbGpPWpGaD
Ziprasidone—DRD4—Signaling by GPCR—HTR2A—conduct disorder	3.18e-05	0.000254	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—WASF1—conduct disorder	3.17e-05	0.000253	CbGpPWpGaD
Ziprasidone—DRD1—GPCR downstream signaling—HTR2A—conduct disorder	3.15e-05	0.000251	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling by GPCR—HTR2A—conduct disorder	3.14e-05	0.00025	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CGA—conduct disorder	3.13e-05	0.000249	CbGpPWpGaD
Ziprasidone—DRD3—GPCR downstream signaling—HTR2A—conduct disorder	3.11e-05	0.000248	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—WASF1—conduct disorder	3.09e-05	0.000246	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—WASF1—conduct disorder	3.04e-05	0.000242	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—DRD4—conduct disorder	3.01e-05	0.00024	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—DRD4—conduct disorder	3.01e-05	0.00024	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling by GPCR—HTR2A—conduct disorder	3e-05	0.00024	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—DRD4—conduct disorder	2.99e-05	0.000238	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	2.97e-05	0.000236	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—DRD4—conduct disorder	2.93e-05	0.000233	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—HTR2A—conduct disorder	2.88e-05	0.000229	CbGpPWpGaD
Ziprasidone—DRD1—Signaling by GPCR—HTR2A—conduct disorder	2.86e-05	0.000228	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—DRD4—conduct disorder	2.84e-05	0.000226	CbGpPWpGaD
Ziprasidone—DRD3—Signaling by GPCR—HTR2A—conduct disorder	2.82e-05	0.000225	CbGpPWpGaD
Ziprasidone—ADRA2B—GPCR downstream signaling—HTR2A—conduct disorder	2.81e-05	0.000224	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—WASF1—conduct disorder	2.8e-05	0.000223	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—WASF1—conduct disorder	2.76e-05	0.00022	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—WASF1—conduct disorder	2.75e-05	0.000219	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—WASF1—conduct disorder	2.74e-05	0.000219	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—WASF1—conduct disorder	2.73e-05	0.000218	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—DRD4—conduct disorder	2.72e-05	0.000217	CbGpPWpGaD
Ziprasidone—HTR1A—GPCR downstream signaling—HTR2A—conduct disorder	2.71e-05	0.000216	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—WASF1—conduct disorder	2.71e-05	0.000216	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—WASF1—conduct disorder	2.7e-05	0.000215	CbGpPWpGaD
Ziprasidone—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	2.7e-05	0.000215	CbGpPWpGaD
Ziprasidone—ADRA2C—GPCR downstream signaling—HTR2A—conduct disorder	2.62e-05	0.000209	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—DRD4—conduct disorder	2.59e-05	0.000207	CbGpPWpGaD
Ziprasidone—ADRA1B—GPCR downstream signaling—HTR2A—conduct disorder	2.58e-05	0.000206	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—DRD4—conduct disorder	2.56e-05	0.000204	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling by GPCR—HTR2A—conduct disorder	2.55e-05	0.000203	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—HTR2A—conduct disorder	2.55e-05	0.000203	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—WASF1—conduct disorder	2.51e-05	0.0002	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling by GPCR—HTR2A—conduct disorder	2.46e-05	0.000196	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	2.45e-05	0.000195	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—CGA—conduct disorder	2.44e-05	0.000194	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling by GPCR—HTR2A—conduct disorder	2.38e-05	0.00019	CbGpPWpGaD
Ziprasidone—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	2.38e-05	0.00019	CbGpPWpGaD
Ziprasidone—ADRA2B—Hemostasis—EP300—conduct disorder	2.35e-05	0.000188	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling by GPCR—HTR2A—conduct disorder	2.34e-05	0.000187	CbGpPWpGaD
Ziprasidone—HRH1—GPCR downstream signaling—HTR2A—conduct disorder	2.34e-05	0.000186	CbGpPWpGaD
Ziprasidone—CHRM1—GPCR downstream signaling—HTR2A—conduct disorder	2.33e-05	0.000186	CbGpPWpGaD
Ziprasidone—CHRM3—GPCR downstream signaling—HTR2A—conduct disorder	2.32e-05	0.000185	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—DRD4—conduct disorder	2.31e-05	0.000184	CbGpPWpGaD
Ziprasidone—CHRM2—GPCR downstream signaling—HTR2A—conduct disorder	2.3e-05	0.000183	CbGpPWpGaD
Ziprasidone—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	2.29e-05	0.000183	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—DRD4—conduct disorder	2.23e-05	0.000178	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—DRD4—conduct disorder	2.22e-05	0.000177	CbGpPWpGaD
Ziprasidone—ADRA2C—Hemostasis—EP300—conduct disorder	2.2e-05	0.000175	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—HTR2A—conduct disorder	2.16e-05	0.000172	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—DRD4—conduct disorder	2.16e-05	0.000172	CbGpPWpGaD
Ziprasidone—CYP3A7—Metabolism—COMT—conduct disorder	2.14e-05	0.000171	CbGpPWpGaD
Ziprasidone—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	2.13e-05	0.00017	CbGpPWpGaD
Ziprasidone—CYP3A7—Metabolism—MAOA—conduct disorder	2.13e-05	0.000169	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—DRD4—conduct disorder	2.12e-05	0.000169	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—HTR2A—conduct disorder	2.12e-05	0.000169	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—HTR2A—conduct disorder	2.12e-05	0.000169	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—HTR2A—conduct disorder	2.11e-05	0.000168	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—HTR2A—conduct disorder	2.09e-05	0.000166	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	2.08e-05	0.000166	CbGpPWpGaD
Ziprasidone—ADRA2C—Metabolism—COMT—conduct disorder	2.08e-05	0.000166	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—CGA—conduct disorder	2.07e-05	0.000165	CbGpPWpGaD
Ziprasidone—ADRA2C—Metabolism—MAOA—conduct disorder	2.06e-05	0.000165	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—HTR2A—conduct disorder	1.96e-05	0.000157	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—HTR2A—conduct disorder	1.96e-05	0.000156	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—DRD4—conduct disorder	1.96e-05	0.000156	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—HTR2A—conduct disorder	1.95e-05	0.000155	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	1.94e-05	0.000154	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—DRD4—conduct disorder	1.93e-05	0.000154	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—DRD4—conduct disorder	1.92e-05	0.000153	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—DRD4—conduct disorder	1.92e-05	0.000153	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—DRD4—conduct disorder	1.91e-05	0.000152	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—HTR2A—conduct disorder	1.91e-05	0.000152	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—DRD4—conduct disorder	1.89e-05	0.000151	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—DRD4—conduct disorder	1.89e-05	0.00015	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—HTR2A—conduct disorder	1.88e-05	0.00015	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—HTR2A—conduct disorder	1.85e-05	0.000148	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—COMT—conduct disorder	1.84e-05	0.000147	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—MAOA—conduct disorder	1.83e-05	0.000146	CbGpPWpGaD
Ziprasidone—ADRA2A—Hemostasis—EP300—conduct disorder	1.79e-05	0.000142	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—HTR2A—conduct disorder	1.77e-05	0.000141	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—DRD4—conduct disorder	1.75e-05	0.00014	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—HTR2A—conduct disorder	1.69e-05	0.000135	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—COMT—conduct disorder	1.69e-05	0.000135	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—MAOA—conduct disorder	1.68e-05	0.000134	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—HTR2A—conduct disorder	1.67e-05	0.000133	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—CGA—conduct disorder	1.59e-05	0.000127	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—COMT—conduct disorder	1.55e-05	0.000123	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—MAOA—conduct disorder	1.54e-05	0.000123	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—EP300—conduct disorder	1.52e-05	0.000121	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—HTR2A—conduct disorder	1.51e-05	0.00012	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—HTR2A—conduct disorder	1.45e-05	0.000116	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—HTR2A—conduct disorder	1.45e-05	0.000115	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—HTR2A—conduct disorder	1.41e-05	0.000112	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—HTR2A—conduct disorder	1.39e-05	0.00011	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—EP300—conduct disorder	1.35e-05	0.000108	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—HTR2A—conduct disorder	1.28e-05	0.000102	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—HTR2A—conduct disorder	1.25e-05	9.99e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—HTR2A—conduct disorder	1.25e-05	9.96e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—HTR2A—conduct disorder	1.25e-05	9.93e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—HTR2A—conduct disorder	1.23e-05	9.83e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	1.23e-05	9.81e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	1.14e-05	9.11e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—COMT—conduct disorder	1.1e-05	8.77e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—MAOA—conduct disorder	1.09e-05	8.71e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—EP300—conduct disorder	1.04e-05	8.3e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—EP300—conduct disorder	1.04e-05	8.29e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—EP300—conduct disorder	1.03e-05	8.23e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—EP300—conduct disorder	1.01e-05	8.06e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—EP300—conduct disorder	9.95e-06	7.93e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—EP300—conduct disorder	9.82e-06	7.83e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—EP300—conduct disorder	9.4e-06	7.5e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—COMT—conduct disorder	9.32e-06	7.43e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—MAOA—conduct disorder	9.26e-06	7.38e-05	CbGpPWpGaD
Ziprasidone—CYP3A7—Metabolism—EP300—conduct disorder	9.18e-06	7.32e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	8.98e-06	7.16e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—EP300—conduct disorder	8.96e-06	7.14e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Metabolism—EP300—conduct disorder	8.92e-06	7.11e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—EP300—conduct disorder	8.84e-06	7.05e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—EP300—conduct disorder	7.98e-06	6.36e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—EP300—conduct disorder	7.89e-06	6.29e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—EP300—conduct disorder	7.71e-06	6.14e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—EP300—conduct disorder	7.67e-06	6.11e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—EP300—conduct disorder	7.46e-06	5.94e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—EP300—conduct disorder	7.34e-06	5.85e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—EP300—conduct disorder	7.24e-06	5.77e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—COMT—conduct disorder	7.2e-06	5.74e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—MAOA—conduct disorder	7.14e-06	5.7e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—EP300—conduct disorder	6.77e-06	5.39e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—EP300—conduct disorder	6.66e-06	5.31e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—EP300—conduct disorder	6.64e-06	5.29e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—EP300—conduct disorder	6.64e-06	5.29e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—EP300—conduct disorder	6.62e-06	5.28e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—EP300—conduct disorder	6.6e-06	5.26e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—EP300—conduct disorder	6.54e-06	5.21e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—EP300—conduct disorder	6.52e-06	5.2e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—EP300—conduct disorder	6.06e-06	4.83e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—EP300—conduct disorder	4.72e-06	3.76e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—EP300—conduct disorder	4e-06	3.19e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—EP300—conduct disorder	3.09e-06	2.46e-05	CbGpPWpGaD
